CN105561191A - Ointment for treating hypertrophy of nasal turbinate - Google Patents

Ointment for treating hypertrophy of nasal turbinate Download PDF

Info

Publication number
CN105561191A
CN105561191A CN201610006943.4A CN201610006943A CN105561191A CN 105561191 A CN105561191 A CN 105561191A CN 201610006943 A CN201610006943 A CN 201610006943A CN 105561191 A CN105561191 A CN 105561191A
Authority
CN
China
Prior art keywords
parts
herba
ointment
rhizoma
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610006943.4A
Other languages
Chinese (zh)
Inventor
师洪亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610006943.4A priority Critical patent/CN105561191A/en
Publication of CN105561191A publication Critical patent/CN105561191A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/264—Aristolochia (Dutchman's pipe)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296—Epimedium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/808—Scrophularia (figwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an ointment for treating hypertrophy of nasal turbinate. The ointment is prepared from the following raw materials in parts by weight: 5 to 7 parts of corydalis tuber, 2 to 4 parts of xanthium, 5 to 7 parts of spatholobus stem, 8 to 10 parts of cooked rhubarb, 3 to 5 parts of polyporus, 2 to 4 parts of oyster, 5 to 6 parts of radix scrophulariae, 8 to 10 parts of cherokee rose fruit, 2 to 3 parts of curcuma rhizome, 6 to 8 parts of cassia twig, 4 to 6 parts of plantain seed, 2 to 3 parts of deer horn cream, 4 to 6 parts of epimedium, 6 to 8 parts of prepared myrrh, 4 to 5 parts of sarcandra glabra, 2 to 4 parts of aristolochia mollissima, 6 to 8 parts of obscured homalomena rhizome, 10 to 15 parts of Indian lettuce, and 4 to 5 parts of maesa perlarius. The raw materials are compounded to generate a synergetic effect. The ointment has the functions of nourishing yin and blood, tonifying liver and kidney, freeing collaterals, activating blood, promoting urination, and eliminating swelling, is completely prepared from traditional Chinese herbals, has the advantages of little side and toxic effect, wide raw material source, low cost, and good curative effect, and is suitable for clinical application.

Description

A kind of ointment for the treatment of nasal conchae hypertrophy
Technical field
The present invention relates to a kind of ointment for the treatment of nasal conchae hypertrophy, belong to the field of Chinese medicines.
Background technology
Nasal conchae hypertrophy refers to that the stimulation that concha nasalis is subject to inflammation for a long time causes concha nasalis mucosa edema, causes congestion. for the concha nasalis inferior of some hypertrophy, use nasal membrane vasoconstrictor and Chinese and western drugs treatment, less effective; Except Drug therapy, the method improving BITONG gas also has partial inferior turbinectomy, freezing, microwave, laser and nasal polyp sickle Partial Resection etc.; But said method is comparatively large to concha nasalis inferior mucosa injury, postoperative pain is hemorrhage, incrustation, dry, nasal cavity abnormal flavour, and infect, adhesion of nasal cavity, affects the function of nasal cavity in various degree.
Summary of the invention
The object of the present invention is to provide a kind of ointment for the treatment of nasal conchae hypertrophy.
The present invention adopts following technical scheme:
The ointment for the treatment of nasal conchae hypertrophy, the weight portion of its constitutive material is: Rhizoma Corydalis 5-7, Fructus Xanthii 2-4, Caulis Spatholobi 5-7, Radix Et Rhizoma Rhei 8-10, Polyporus 3-5, Concha Ostreae 2-4, Radix Scrophulariae 5-6, Fructus Rosae Laevigatae 8-10, Rhizoma Curcumae 2-3, Ramulus Cinnamomi 6-8, Semen Plantaginis 4-6, Cornu Cervi Degelatinatum 2-3, Herba Epimedii 4-6, Myrrha (processed) 6-8, Herba Pileae Scriptae 4-5, Herba Aristolochiae Mollissimae 2-4, Rhizoma Homalomenae 6-8, Herba Ixeritis Denticulatae 10-15, Herba Maesae Prelarii 4-5.
The ointment for the treatment of nasal conchae hypertrophy, the weight portion of its constitutive material is: Rhizoma Corydalis 6, Fructus Xanthii 3, Caulis Spatholobi 6, Radix Et Rhizoma Rhei 9, Polyporus 4, Concha Ostreae 3, Radix Scrophulariae 5, Fructus Rosae Laevigatae 9, Rhizoma Curcumae 2, Ramulus Cinnamomi 7, Semen Plantaginis 5, Cornu Cervi Degelatinatum 2, Herba Epimedii 5, Myrrha (processed) 7, Herba Pileae Scriptae 4.5, Herba Aristolochiae Mollissimae 3, Rhizoma Homalomenae 7, Herba Ixeritis Denticulatae 12, Herba Maesae Prelarii 4.5.
Consumption and usage: take each raw material by the weight portion of constitutive material, grind, then add appropriate paraffin oil and reconcile into pasty state, be coated on outside nasal cavity, every day 1-2 time, and 10 days is a course for the treatment of, and general 2-3 can cure a course for the treatment of.
Beneficial effect of the present invention:
The all medicine compatibilities of Chinese medicine of the present invention, have nourishing YIN and benefiting blood, adjusting and reinforcing liver and kidney, dredging collateral is invigorated blood circulation, effect of inducing diuresis to remove edema; And the present invention is a kind of pure Chinese medicinal preparation, toxic and side effects is little, and medicine source is wide, cost is low, curative effect is high, suggestion clinical application.
Detailed description of the invention
Embodiment 1: the ointment for the treatment of nasal conchae hypertrophy, the weight portion (g) of its constitutive material is: Rhizoma Corydalis 6, Fructus Xanthii 3, Caulis Spatholobi 6, Radix Et Rhizoma Rhei 9, Polyporus 4, Concha Ostreae 3, Radix Scrophulariae 5, Fructus Rosae Laevigatae 9, Rhizoma Curcumae 2, Ramulus Cinnamomi 7, Semen Plantaginis 5, Cornu Cervi Degelatinatum 2, Herba Epimedii 5, Myrrha (processed) 7, Herba Pileae Scriptae 4.5, Herba Aristolochiae Mollissimae 3, Rhizoma Homalomenae 7, Herba Ixeritis Denticulatae 12, Herba Maesae Prelarii 4.5.
Consumption and usage: take each raw material by the weight portion of constitutive material, grind, then add appropriate paraffin oil and reconcile into pasty state, be coated on outside nasal cavity, every day 1-2 time, and 10 days is a course for the treatment of, and general 2-3 can cure a course for the treatment of.
Model case:
Model case 1: side certain, female, 43 years old, suffer from nasal conchae hypertrophy, often feel congestion, companioned with headache, dizziness, hypomnesis time serious, chest pain, the ill symptoms such as uncomfortable in chest, apply ointment of the present invention, every day 1 time, be coated on outside nasal cavity, connect a course for the treatment of of painting, nasal obstruction is clearly better, no headache, dizziness, two courses for the treatment of of subsequent coated, all diseases disappear entirely, and concha nasalis is without hypertrophy.
Model case 2: Lee, man, 48 years old, suffer from nasal conchae hypertrophy, nasal obstruction is serious, and olfactory sensation is also constantly gone down, companioned with headache time serious, dizziness, chest pain, the general malaise symptom such as uncomfortable in chest, apply ointment of the present invention, every day 2 times, connect three courses for the treatment of of painting, all diseases disappear entirely, without nasal obstruction, check that concha nasalis size recovers normal.

Claims (2)

1. treat an ointment for nasal conchae hypertrophy, it is characterized in that the weight portion of its constitutive material is: Rhizoma Corydalis 5-7, Fructus Xanthii 2-4, Caulis Spatholobi 5-7, Radix Et Rhizoma Rhei 8-10, Polyporus 3-5, Concha Ostreae 2-4, Radix Scrophulariae 5-6, Fructus Rosae Laevigatae 8-10, Rhizoma Curcumae 2-3, Ramulus Cinnamomi 6-8, Semen Plantaginis 4-6, Cornu Cervi Degelatinatum 2-3, Herba Epimedii 4-6, Myrrha (processed) 6-8, Herba Pileae Scriptae 4-5, Herba Aristolochiae Mollissimae 2-4, Rhizoma Homalomenae 6-8, Herba Ixeritis Denticulatae 10-15, Herba Maesae Prelarii 4-5.
2. the ointment for the treatment of nasal conchae hypertrophy according to claim 1, is characterized in that the weight portion of its constitutive material is: Rhizoma Corydalis 6, Fructus Xanthii 3, Caulis Spatholobi 6, Radix Et Rhizoma Rhei 9, Polyporus 4, Concha Ostreae 3, Radix Scrophulariae 5, Fructus Rosae Laevigatae 9, Rhizoma Curcumae 2, Ramulus Cinnamomi 7, Semen Plantaginis 5, Cornu Cervi Degelatinatum 2, Herba Epimedii 5, Myrrha (processed) 7, Herba Pileae Scriptae 4.5, Herba Aristolochiae Mollissimae 3, Rhizoma Homalomenae 7, Herba Ixeritis Denticulatae 12, Herba Maesae Prelarii 4.5.
CN201610006943.4A 2016-01-07 2016-01-07 Ointment for treating hypertrophy of nasal turbinate Pending CN105561191A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610006943.4A CN105561191A (en) 2016-01-07 2016-01-07 Ointment for treating hypertrophy of nasal turbinate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610006943.4A CN105561191A (en) 2016-01-07 2016-01-07 Ointment for treating hypertrophy of nasal turbinate

Publications (1)

Publication Number Publication Date
CN105561191A true CN105561191A (en) 2016-05-11

Family

ID=55872199

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610006943.4A Pending CN105561191A (en) 2016-01-07 2016-01-07 Ointment for treating hypertrophy of nasal turbinate

Country Status (1)

Country Link
CN (1) CN105561191A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110448674A (en) * 2019-08-16 2019-11-15 河南壹哆康健康科技有限公司 For treating concha hypertrophy, powder of nasal polyp and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1634222A (en) * 2004-10-11 2005-07-06 王学安 Medicine for treating chronic rhinitis
CN101849992A (en) * 2010-06-08 2010-10-06 胡学岚 Medicament for treating inferior turbinate hypertrophy and method for preparing same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1634222A (en) * 2004-10-11 2005-07-06 王学安 Medicine for treating chronic rhinitis
CN101849992A (en) * 2010-06-08 2010-10-06 胡学岚 Medicament for treating inferior turbinate hypertrophy and method for preparing same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张颖等: "中药治疗变应性鼻炎用药特点及分析", 《中国中医药信息杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110448674A (en) * 2019-08-16 2019-11-15 河南壹哆康健康科技有限公司 For treating concha hypertrophy, powder of nasal polyp and preparation method thereof

Similar Documents

Publication Publication Date Title
KR100643880B1 (en) Composition of medicinal herbs for treating rhinitis, empyema, bronchitis and tympanitis
CN1315525C (en) Chinese traditional medicine for treating breast disease and preparing technique
CN101564521A (en) External plaster for treating hyperplasia of mammary glands
CN104771461A (en) Traditional Chinese medicine spraying agent for treating acne and preparation method thereof
CN105561191A (en) Ointment for treating hypertrophy of nasal turbinate
CN100522215C (en) Traditional Chinese medicine composition for treating traumatic injury and bone fracture
CN103100010A (en) Drug for treatment of rheumatic arthritis
CN105012642B (en) A kind of promoting blood circulation and removing blood stasis, preparation method of the Chinese medicine composition of hemostasis and pain-relieving
CN104147562A (en) Traditional Chinese medicine (TCM) for treating chronic pelvic inflammatory diseases caused by congealing cold-damp
CN104998019B (en) A kind of promoting blood circulation and removing blood stasis, Chinese medicine composition of hemostasis and pain-relieving
CN111658748A (en) Composition for treating dysmenorrhea, oral preparation and application
CN103417787A (en) Traditional Chinese medicine drug granules used for prevention and treatment of pig dysentery and preparation method of traditional Chinese medicine drug granules
CN102940814B (en) Medicine for treating tubal nowhere
CN107468870A (en) It is a kind of to be used to treat ointment medicine of dermatitis and preparation method thereof
CN100502939C (en) Suppository for eliminating vagina diseases
CN104107355A (en) Ointment for invigorating splenic yang and dispelling fire
CN105616947A (en) Heat and dampness removing traditional Chinese medicine for treating acute gouty arthritis
CN105434730A (en) External traditional Chinese medicine for treating mange
CN104826011A (en) Medicinal liquor with rapid effect
CN104547753A (en) Blood-activating and swelling-removing traditional Chinese medicine formula special for treating acute or chronic appendicitis
CN104096037A (en) Traditional Chinese medicine capsule for treating breast hyperplasia
CN104922397B (en) A kind of promoting blood circulation and removing blood stasis, application of the Chinese medicine composition of hemostasis and pain-relieving
CN105617253A (en) Traditional Chinese medicine for treating rhinoscleroma
CN104689235B (en) A kind of Chinese medicine composition for treating women scapulohumeral periarthritis
CN102895468B (en) Traditional Chinese medicine (TCM) preparation for treating psoriasis and preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160511

RJ01 Rejection of invention patent application after publication